312 related articles for article (PubMed ID: 35406442)
1. A Review of the Current Impact of Inhibitors of Apoptosis Proteins and Their Repression in Cancer.
Cetraro P; Plaza-Diaz J; MacKenzie A; Abadía-Molina F
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406442
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Small Molecules Target Inhibitor of Apoptosis Proteins in Cancers with Deregulation of Extrinsic and Intrinsic Cell Death Pathways.
Derakhshan A; Chen Z; Van Waes C
Clin Cancer Res; 2017 Mar; 23(6):1379-1387. PubMed ID: 28039268
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Potent SMAC Mimetics that Sensitize Cancer Cells to TNF Family-Induced Apoptosis.
Welsh K; Milutinovic S; Ardecky RJ; Gonzalez-Lopez M; Ganji SR; Teriete P; Finlay D; Riedl S; Matsuzawa S; Pinilla C; Houghten R; Vuori K; Reed JC; Cosford ND
PLoS One; 2016; 11(9):e0161952. PubMed ID: 27617834
[TBL] [Abstract][Full Text] [Related]
4. Overcoming cancer therapy resistance by targeting inhibitors of apoptosis proteins and nuclear factor-kappa B.
Dai Y; Lawrence TS; Xu L
Am J Transl Res; 2009; 1(1):1-15. PubMed ID: 19966933
[TBL] [Abstract][Full Text] [Related]
5. A Smac-mimetic sensitizes prostate cancer cells to TRAIL-induced apoptosis via modulating both IAPs and NF-kappaB.
Dai Y; Liu M; Tang W; Li Y; Lian J; Lawrence TS; Xu L
BMC Cancer; 2009 Nov; 9():392. PubMed ID: 19895686
[TBL] [Abstract][Full Text] [Related]
6. Chalepin: A Compound from
Richardson JSM; Aminudin N; Abd Malek SN
Pharmacogn Mag; 2017 Oct; 13(Suppl 3):S489-S498. PubMed ID: 29142404
[TBL] [Abstract][Full Text] [Related]
7. Smac mimetic suppresses tunicamycin-induced apoptosis via resolution of ER stress.
Abhari BA; McCarthy N; Le Berre M; Kilcoyne M; Joshi L; Agostinis P; Fulda S
Cell Death Dis; 2019 Feb; 10(3):155. PubMed ID: 30770792
[TBL] [Abstract][Full Text] [Related]
8. Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism.
Allensworth JL; Sauer SJ; Lyerly HK; Morse MA; Devi GR
Breast Cancer Res Treat; 2013 Jan; 137(2):359-71. PubMed ID: 23225169
[TBL] [Abstract][Full Text] [Related]
9. Structure-based design and molecular profiling of Smac-mimetics selective for cellular IAPs.
Corti A; Milani M; Lecis D; Seneci P; de Rosa M; Mastrangelo E; Cossu F
FEBS J; 2018 Sep; 285(17):3286-3298. PubMed ID: 30055105
[TBL] [Abstract][Full Text] [Related]
10. X-linked inhibitor of apoptosis (XIAP) blocks Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis of prostate cancer cells in the presence of mitochondrial activation: sensitization by overexpression of second mitochondria-derived activator of caspase/direct IAP-binding protein with low pl (Smac/DIABLO).
Ng CP; Bonavida B
Mol Cancer Ther; 2002 Oct; 1(12):1051-8. PubMed ID: 12481428
[TBL] [Abstract][Full Text] [Related]
11. SMAC mimetics inhibit human T cell proliferation and fail to augment type 1 cytokine responses.
Burton AM; Ligman BR; Kearney CA; Murray SE
Cell Immunol; 2023 Feb; 384():104674. PubMed ID: 36706656
[TBL] [Abstract][Full Text] [Related]
12. The Immuno-Modulatory Effects of Inhibitor of Apoptosis Protein Antagonists in Cancer Immunotherapy.
Michie J; Kearney CJ; Hawkins ED; Silke J; Oliaro J
Cells; 2020 Jan; 9(1):. PubMed ID: 31947615
[TBL] [Abstract][Full Text] [Related]
13. Bivalent SMAC Mimetics for Treating Cancer by Antagonizing Inhibitor of Apoptosis Proteins.
Zhu H; Li Y; Liu Y; Han B
ChemMedChem; 2019 Dec; 14(23):1951-1962. PubMed ID: 31692274
[TBL] [Abstract][Full Text] [Related]
14. A small molecule Smac-mimic compound induces apoptosis and sensitizes TRAIL- and etoposide-induced apoptosis in breast cancer cells.
Bockbrader KM; Tan M; Sun Y
Oncogene; 2005 Nov; 24(49):7381-8. PubMed ID: 16044155
[TBL] [Abstract][Full Text] [Related]
15. The SMAC mimetic BV6 induces cell death and sensitizes different cell lines to TNF-α and TRAIL-induced apoptosis.
El-Mesery M; Shaker ME; Elgaml A
Exp Biol Med (Maywood); 2016 Dec; 241(18):2015-2022. PubMed ID: 27465142
[TBL] [Abstract][Full Text] [Related]
16. Smac mimetics as new cancer therapeutics.
Chen DJ; Huerta S
Anticancer Drugs; 2009 Sep; 20(8):646-58. PubMed ID: 19550293
[TBL] [Abstract][Full Text] [Related]
17. SMAC mimetics as potential cancer therapeutics in myeloid malignancies.
Boddu P; Carter BZ; Verstovsek S; Pemmaraju N
Br J Haematol; 2019 Apr; 185(2):219-231. PubMed ID: 30836448
[TBL] [Abstract][Full Text] [Related]
18. Neutralization of Smac/Diablo by inhibitors of apoptosis (IAPs). A caspase-independent mechanism for apoptotic inhibition.
Wilkinson JC; Wilkinson AS; Scott FL; Csomos RA; Salvesen GS; Duckett CS
J Biol Chem; 2004 Dec; 279(49):51082-90. PubMed ID: 15371416
[TBL] [Abstract][Full Text] [Related]
19. IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.
Armstrong MJ; Stang MT; Liu Y; Yan J; Pizzoferrato E; Yim JH
Cancer Biol Ther; 2015; 16(7):1029-41. PubMed ID: 26011589
[TBL] [Abstract][Full Text] [Related]
20. Inhibitor of apoptosis proteins (IAPs) as regulatory factors of hepatic apoptosis.
Wang K; Lin B
Cell Signal; 2013 Oct; 25(10):1970-80. PubMed ID: 23770286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
